Searched for
ASTRAZENECA DEAL
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
Banquets and billions: How AstraZeneca sealed a US medicine deal with TrumpAstraZeneca CEO Pascal Soriot met with U.S. President Donald Trump to finalize a medicine deal. This agreement will lower drug prices for m...
AstraZeneca signs AI research deal with China's CSPC for chronic diseasesUnder Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule or...
AstraZeneca to buy EsoBiotec for up to $1 billionAstraZeneca is set to acquire biotechnology firm EsoBiotec for up to $1 billion, including a $425 million upfront payment and up to $575 mi...
AstraZeneca to buy China's Gracell Bio for up to $1.2 billionThe cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per AD...
AstraZeneca, AI biologics firm Absci tie up on cancer drugAbsci's collaboration with AstraZeneca aims for a zero-shot generative AI model designed to create new and improved antibody therapeutics
UK probes mega AstraZeneca deal for US biotech firmIn a brief statement, the Competition and Markets Authority said it was looking at whether the deal would "result in a substantial lessenin...
EU seeks new COVID-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU- SourcesThe European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the do...
EU seeks answers from AstraZeneca on cut to vaccine supplies in Monday meetingAstraZeneca, which developed its shot with Oxford University, told the EU on Friday that it could not meet the agreed supply targets runnin...
AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
AstraZeneca sells cholesterol drug rights to GrĂ¼nenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
AstraZeneca gets extension for Meronem withdrawal till August 31The product is currently one of the company's principal products which generated 18 per cent total turnover of the firm in fiscal ended Mar...
AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...
Under Sebi lens, Elliott offloads 6% in AstraZenecaSebi’s deadline to investigate dealings of the Elliott Group with regard to the de-listing of Astra-Zeneca ended on March 11.
AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
Pfizer has not discussed AstraZeneca bid with regulators: European Union's AlmuniaPfizer is seeking to acquire Britain's second-biggest drugmaker and may have to sweeten its offer after AstraZeneca rejected the bid.
Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
- HCL Technologies replaces IBM as IT infra vendor of AstraZeneca
HCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.